Anika Therapeutics, Inc. (ANIK)
15.28
-0.02
(-0.13%)
USD |
NASDAQ |
Apr 15, 16:00
15.28
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Research and Development Expense (Annual) : 25.77M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 164.74M |
| Masimo Corp. | 126.40M |
| Lantheus Holdings, Inc. | 177.31M |
| Evolus, Inc. | 9.576M |
| TELA Bio, Inc. | 9.22M |